Agenus, a Lexington, MA-based immuno-oncology firm creating new therapeutics for high-unmet want cancers, obtained an funding from Zynext…
Feldan Therapeutics, a Québec Metropolis, Québec, Canada-based early clinical-stage pharmaceutical firm, obtained an funding from Zynext Ventures. The quantity…
Illexcor Therapeutics, a Richmond, VA-based biopharmaceutical firm growing new oral therapies for sickle cell illness (SCD), acquired an…
neuro42, a San Francisco, CA-based developer of moveable MRI methods for neuroimaging and interventions, acquired an funding from…
Sign in to your account